1. Home
  2. Investing
  3. Stocks
  4. USA
  6. CRISPR Therapeutics AG (CRSP)
  7. Quote


CRISPR Therapeutics Stock Price

-6.85 (-8.91%)
Upgrade to Real-Time
Afterhours (Closed)
Volume 2,892,812
Bid Price 69.84
Ask Price 70.24
News -
Day High 76.85


52 Week Range


Day Low 68.1606
Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
Canadian Level 1 + USA
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
CRISPR Therapeutics AG CRSP NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-6.85 -8.91% 70.00 20:00:01
Open Price Low Price High Price Close Price Prev Close
76.85 68.1606 76.85 70.09 76.85
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
53,153 2,892,812 $ 71.66 $ 207,294,638 - 68.1606 - 220.21
Last Trade Time Type Quantity Stock Price Currency
19:59:28 5 $ 69.84 USD


Draw Mode:

CRISPR Therapeutics AG Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 5.36B 76.53M 52.74M $ 719.00k $ 328.15k -5.29 15.90
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 152.45k 2.00%

more financials information »

CRISPR Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical CRSP Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week79.5782.0068.160677.741,362,636-9.57-12.03%
1 Month93.077595.0068.160683.511,396,666-23.08-24.79%
3 Months122.43124.7968.160696.711,430,815-52.43-42.82%
6 Months112.94169.6768.1606114.931,327,383-42.94-38.02%
1 Year132.89220.2168.1606132.931,658,224-62.89-47.32%
3 Years39.95220.2121.6596.321,116,15530.0575.22%
5 Years19.10220.2111.6382.67920,39850.90266.49%

CRISPR Therapeutics Description

CRISPR Therapeutics AG is a gene-editing company. It is engaged in the development of CRISPR/Cas9-based therapeutics. CRISPR/Cas9 is a technology that allows for precise, directed changes to genomic DNA. The company advanced programs target beta-thalassemia and sickle cell disease, two hemoglobinopathies that have a high unmet medical need.

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.